Neurofibromatosis Type 2-Yes-Associated Protein and Transcriptional Coactivator With PDZ-Binding Motif Dual Immunohistochemistry Is a Reliable Marker for the Detection of Neurofibromatosis Type 2 Alterations in Diffuse Pleural Mesothelioma-Reference-Cited by-同舟云学术

Neurofibromatosis Type 2-Yes-Associated Protein and Transcriptional Coactivator With PDZ-Binding Motif Dual Immunohistochemistry Is a Reliable Marker for the Detection of Neurofibromatosis Type 2 Alterations in Diffuse Pleural Mesothelioma

Published:2023-03 Issue:3 Volume:36 Page:100030
ISSN:0893-3952
Container-title:Modern Pathology
language:en
Short-container-title:Modern Pathology

Author:

Li Yan,Yang Soo-Ryum,Chen Ying-Bei,Adusumilli Prasad S.,Bialik Ann,Bodd Francis M.,Ladanyi Marc,Lopardo Jessica,Offin Michael D.,Rusch Valerie W.,Travis William D.,Zauderer Marjorie G.,Chang Jason C.,Sauter Jennifer L.^ORCID

Funder

National Cancer Institute

National Institutes of Health

Publisher

Elsevier BV

Subject

Pathology and Forensic Medicine

Reference62 articles.

1. Advances in malignant mesothelioma;Robinson;N Engl J Med,2005

2. Current and future management of malignant mesothelioma: a consensus report from the National Cancer Institute Thoracic Malignancy Steering Committee, International Association for the Study of Lung Cancer, and Mesothelioma Applied Research Foundation;Tsao;J Thorac Oncol,2018

3. Malignant mesothelioma: facts, myths, and hypotheses;Carbone;J Cell Physiol,2012

4. Relapse patterns and tailored treatment strategies for malignant pleural mesothelioma recurrence after multimodality therapy;Bellini;J Clin Med,2021

5. Phase II study of hemithoracic intensity-modulated pleural radiation therapy (IMPRINT) as part of lung-sparing multimodality therapy in patients with malignant pleural mesothelioma;Rimner;J Clin Oncol,2016

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mesothelioma: molecular pathology and biomarkers;Die Pathologie;2024-08-07

2. Separation of Benign From Malignant Mesothelial Proliferations Using YAP-TAZ Immunohistochemistry;Modern Pathology;2024-05

3. Diffuse Pleural Mesothelioma: Advances in Molecular Pathogenesis, Diagnosis, and Treatment;Annual Review of Pathology: Mechanisms of Disease;2024-01-24

4. Molecular and Immunohistochemical Testing in Mesothelioma and Other Mesothelial Lesions;Archives of Pathology & Laboratory Medicine;2024-01-08

5. New developments in mesothelial pathology;Histopathology;2023-09-11